
DeepkinetiX is an AI-powered software and services company focused on optimizing drug development through Model-Informed Drug Development (MIDD) and AI-driven predictive insights. Their SaaS platform, KinetixFlow™, aims to reduce R&D costs and time by providing precise PK/PD, PBPK, and QSP modeling. The company offers a cost-effective, faster, more precise, and ethically superior alternative to traditional animal-based methods by leveraging digital twin technology to accurately predict effective dosages and potential clinical side effects of drug candidates during early development stages. This accelerates R&D, reduces costs, and expedites the path to market, ultimately aiming for faster delivery of lifesaving therapies.

DeepkinetiX is an AI-powered software and services company focused on optimizing drug development through Model-Informed Drug Development (MIDD) and AI-driven predictive insights. Their SaaS platform, KinetixFlow™, aims to reduce R&D costs and time by providing precise PK/PD, PBPK, and QSP modeling. The company offers a cost-effective, faster, more precise, and ethically superior alternative to traditional animal-based methods by leveraging digital twin technology to accurately predict effective dosages and potential clinical side effects of drug candidates during early development stages. This accelerates R&D, reduces costs, and expedites the path to market, ultimately aiming for faster delivery of lifesaving therapies.